Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
-
EPKINLY® (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma
-
Natural gas remains the crucial bridge in the energy transition, yet challenges persist
-
Interim Management Report covering H1 2024/25
-
ParaZero Unlocks Growth Opportunities After Achieving European Regulatory Compliance for its SafeAir Systems
-
Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favo
-
Gold-Rich Cobalt-Copper Mineralization at CAS Property Strengthens Electra’s Idaho Exploration Strategy
-
Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
FTI Consulting Reports Fourth Quarter and Full Year 2024 Financial Results
-
Repligen Reports Fourth Quarter and Full Year 2024 Financial Results
-
Labrador Gold Announces 2025 Exploration Programs for the 100% Owned Hopedale and Borden Lake Gold Projects
-
Mandalay Resources Reports 2024 Mineral Reserves and Resources Approaching Two Million Gold Equivalent Ounces in Measured and Indicated Resources
-
Global Crossing Airlines Sets Fourth Quarter and Full Year 2024 Conference Call for March 6, 2025 at 8:30 a.m. ET
-
Rekor Systems to Announce 2024 Results
-
Western Upper Peninsula Communities Demonstrate Continued Support for the Copperwood Mine Project
-
VR Resources Completes Drilling at Silverback Copper-Gold Project in Northwest Ontario
-
Plus Therapeutics Appoints Dr. Michael Rosol as Chief Development Officer
-
BT Group Advances Enterprise Service Innovation by Enabling Future-Proven Business Services With Optiva Platform
-
Purpose Investments Expands Yield Shares Lineup with Seven New ETFs, Offering Enhanced Income Opportunities
-
NowVertical Completes Debt-to-Equity Conversions
-
Altimmune to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on February 27, 2025
-
Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
-
Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)
-
Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2024 Earnings and Company Updates
-
Colliers makes 19th consecutive appearance on IAOP’s Global Outsourcing 100
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Commercial Update
-
Laureate Education Reports Financial Results for the Fourth Quarter and Full-Year 2024 and Provides 2025 Outlook
-
MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements
-
Rekor Systems to Announce 2024 Results
-
CoreCard Corporation Reports Fourth Quarter and Full Year 2024 Results
-
Codere Online Reports Financial Results for the Fourth Quarter and Full Year 2024
-
Altisource Announces Closing of the Previously Announced Exchange and Maturity Extension Transactions of the Company’s Term Loans
-
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
-
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
-
PayPoint plc : Holding(s) in Company
-
AS Tallink Grupp Investor Webinar introducing the results of the Q4 and 12 months of 2024
-
Heimar hf.: Acquisition of Exeter Hotel Properties
-
Net Asset Value(s)
-
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
-
The Joint Corp. to Host Conference Call on Thursday, March 13th to Discuss Fourth Quarter and Year-end 2024 Results
-
Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS® for Regulatory Review in China for the Treatment of Uveitic Macular Edema
-
Advanced Technology Recycling (ATR) Announces Readiness to Prioritize Secure Disposal of Restricted Telecommunications Equipment to Ensure Full Reimbursement Compliance
-
TransAlta Reports Strong 2024 Results, Announces Dividend Increase and 2025 Annual Guidance
-
Microchip Extends maXTouch® M1 Generation Family to Support Large, Curved and Shaped Automotive Displays
-
Canadian Product Stewardship Council Appoints Sarah Cotton-Elliott as New CEO
-
Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development
-
Americold Announces Fourth Quarter and Full Year 2024 Results
-
LEEF Brands to Participate in CEM’s Whistler Capital Conference
-
Eloro Resources Further Expands Major Tin Zone with Significant Tin Intersections Highlighted by 49.5m grading 0.55% Sn within 91.5m grading 0.34% Sn in its Definition Drilling Program at its Iska Isk
-
Enviri Corporation Reports Fourth Quarter and Full Year 2024 Results
